G. Meco

16.3k citations

122 papers · 6.7k indexed · 1 hit paper · h-index 42

Impact in

Neurology top 0.1%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neurological diseases and metabolism
Cellular and Molecular Neuroscience top 0.5%
- Nuclear Receptors and Signaling
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research

Papers in

Neurology 94
- Parkinson's Disease Mechanisms and Treatments 85
- Neurological disorders and treatments 45
- Neurological diseases and metabolism 12
- Parkinson's Disease and Spinal Disorders 7
Cellular and Molecular Neuroscience 33
- Nuclear Receptors and Signaling 19
- Genetic Neurodegenerative Diseases 7

Co-authors: Vincenzo Bonifati Nicola Vanacore Ben A. Oostra Alexis Brice Peter Heutink Cornelia M. van Duijn Ferdinando Squitieri Patrizia Rizzu
Journals: Neurological Sciences (17 papers)Acta Neurologica Scandinavica (9 papers)Movement Disorders (7 papers)Neurology (7 papers)Journal of Neural Transmission (6 papers)
Partner nations: Italy Netherlands France

In The Last Decade

G. Meco

122 papers receiving 6.5k citations

Hit Papers

align trajectories log scale

Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism 2003 · 2.2k citations

Peers

Countries citing papers authored by G. Meco

Since Specialization

Citations

This map shows the geographic impact of G. Meco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Meco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Meco more than expected).

Fields of papers citing papers by G. Meco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Meco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Meco. The network helps show where G. Meco may publish in the future.

Co-authorship network

The 25 scholars most cited alongside G. Meco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with G. Meco Line = papers co-authored together G. Meco links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Adaptation and psychometric properties of the Italian version of the Non-Motor Symptoms Questionnaire for Parkinson’s disease Neurological Sciences ·Ilaria Cova, Maria Elena Di Battista, Nicola Vanacore, Chiara Papi, Andres Ordenes Evensen, Alfonso Rubino, Mariarosaria Valente, G. Meco, 傅辉珺, Alessandra Di Pucchio, Eleonora Lacorte, Alberto Priori, C. Mariani, Simone Pomati	2017	4
2	Motor outcomes in patients with advanced Parkinson’s disease treated with levodopa/carbidopa intestinal gel in Italy: an interim analysis from the GREENFIELD observational study Neurological Sciences ·Leonardo Lopiano, Nicola Modugno, Pietro Marano, Mariachiara Sensi, G. Meco, Antonino Cannas, Graziano Gusmaroli, Filippo Tamma, Francesca Mancini, R. Quatrale, Bing Shui, Giuliana Gualberti, Gabriella Melzi, Umberto di Luzio Paparatti, Angelo Antonini	2016	26
3	A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non‐demented Parkinson's disease patients European Journal of Neurology ·Paolo Barone, Gabriella Santangelo, Francesca Morgante, Marco Onofrj, G. Meco, Giovanni Abbruzzese, Ubaldo Bonuccelli, Giovanni Cossu, Gianni Pezzoli, Paolo Stanzione, Leonardo Lopiano, Angelo Antonini, Michèle Tinazzi	2015	79
4	Is cognitive stability in Parkinson’s disease a predictable phenomenon? A 5-year follow-up study Journal of Neural Transmission ·Maria Elena Di Battista, Alfonso Rubino, Sara HAMIDNIA, 裕史笹川, Nicola Vanacore, G. Meco	2015	4
5	l-Acetylcarnitine in dysthymic disorder in elderly patients: A double-blind, multicenter, controlled randomized study vs. fluoxetine European Neuropsychopharmacology ·Giuseppe Bersani, G. Meco, 表谷早紀, Fatma Ezzahra Elassoufi, Прокопович М. Е., Raffaella Nicolai, Francesco Saverio Bersani, Aleardo Koverech	2013	50
6	A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease Expert Opinion on Pharmacotherapy ·Ubaldo Bonuccelli, G. Meco, Giovanni Fabbrini, Alessandro Tessitore, Mariangela Pierantozzi, Fabrizio Stocchi, Roberto Ceravolo, Carlo Caltagirone, Mauro Silvestrini, Francesca Morgante, Stefano Ruggieri, Laura Avanzino, A Lefever, Grazia Dell’Agnello, Andrea Rossi, 学中川, Michele Mancini	2012	24
7	A simplified algorithm may lead to overestimate dementia in PD. A clinical and epidemiological study using criteria for PD-D proposed by the Movement Disorders Task Force Journal of Neural Transmission ·Maria Elena Di Battista, 裕史笹川, Silvia Bernardi, Paola Stirpe, N. Vanacore, G. Meco	2011	15
8	Mortality in a population-based cohort of patients treated with antiparkinsonian drugs Acta Neurologica Scandinavica ·Roberto Raschetti, Stefania Spila Alegiani, N. Vanacore, Carla Ancona, G. Meco	2009	6
9	Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·María Martínez, Alexis Brice, Jenny Vaughan, Alexander Zimprich, Monique M.B. Breteler, G. Meco, Alessandro Filla, Matthew J. Farrer, Christine Bétard, Andrew Singleton, John Hardy, Giuseppe De Michele, Vincenzo Bonifati, Ben A. Oostra, Thomas Gasser, Nicholas Wood, Alexandra Dürr, (unknown)	2005	28
10	Prevalence and clinical features of hedonistic homeostatic dysregulation in Parkinson's disease Movement Disorders ·Francesca Romana Pezzella, Carlo Colosimo, Nicola Vanacore, S. Di Rezze, Jenna Ebbecke, Giovanni Fabbrini, G. Meco	2004	116
11	Autosomal recessive early onset parkinsonism is linked to three loci: PARK2, PARK6, and PARK7 Neurological Sciences ·Vincenzo Bonifati, Marieke Dekker, N. Vanacore, Giovanni Fabbrini, Ferdinando Squitieri, R. Marconi, Angelo Antonini, Lucy McCartan, A. Dalla Libera, Michele De Mari, Fabrizio Stocchi, P. Montagna, Virgilio Gallai, Patrizia Rizzu, John C. van Swieten, Ben A. Oostra, Cornelia M. van Duijn, G. Meco, Peter Heutink	2002	44
12	Epidemiology of multiple system atrophy Neurological Sciences ·N. Vanacore, Vincenzo Bonifati, Giovanni Fabbrini, Carlo Colosimo, Giuseppe De Michele, R. Marconi, David Nicholl, Nicoletta Locuratolo, Giuseppina Talarico, Silvia Romano, Fabrizio Stocchi, Ubaldo Bonuccelli, Michele De Mari, P. Vieregge, G. Meco	2001	41
13	Twenty-four-hour heart rate variability to assess autonomic function in Parkinson's disease Acta Neurologica Scandinavica ·Thanathip Lamkom, N. Vanacore, D Cipris, Nicoletta Locuratolo, Cecil Vella, 美晴五十嵐, L Baratta, Luigi Tubani, G. Meco	1999	33
14	Chromosome 6–Linked Autosomal Recessive Early-Onset Parkinsonism: Linkage in European and Algerian Families, Extension of the Clinical Spectrum, and Evidence of a Small Homozygous Deletion in One Family The American Journal of Human Genetics ·Jean‐Pol Tassin, Alexandra Dürr, T. de Broucker, Nacer Abbas, Vincenzo Bonifati, Giuseppe De Michele, Muriel Bonnet, Emmanuel Broussolle, Pierre Pollak, Marie Vidailhet, Michele De Mari, R. Marconi, C. Martayan, Tokio Inbe, G. Meco, Yves Agid, Alexis Brice	1998	52
15	Buspirone in Levodopa-Induced Dyskinesias Clinical Neuropharmacology ·Vincenzo Bonifati, Edito Fabrizio, J.A. Patell, Nicola Vanacore, G. Meco	1994	140
16	Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients Acta Neurologica Scandinavica ·Verónica Patricia Pitisaca Erique, S. R. Kosslow, Vincenzo Bonifati, G. Meco	1991	13
17	Controlled single blind cross-over study of Ritanserin and placebo in L-Dopa induced dyskinesias in Parkinson's disease Current Therapeutic Research ·G. Meco, Sara Marini, E., Italo Linfante, F. Modarelli, A. Agnoli	1988	17
18	Multicenter trial of L-Deprenylin Parkinson disease Neurological Sciences ·Stefano Ruggieri, 表谷早紀, G. Meco, Angelico Carta, Fabrizio Stocchi, A. Agnoli	1986	7
19	Bromocryptine in clinical neurology Neuroscience Letters ·M Casacchia, G. Meco, Enrico Bertini	1978	1
20	[Treatment of anxiety in Parkinson's disease with bromazepam]. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·M Casacchia, V.M. Vurbanov, John Cartlidge, G. Meco	1975	12

About G. Meco

G. Meco is a scholar working on Neurology, Neurology, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Cognitive Neuroscience, having authored 122 papers that have together received 6.7k indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (85 papers), Neurological disorders and treatments (45 papers), Nuclear Receptors and Signaling (19 papers), Neurological diseases and metabolism (12 papers), Schizophrenia research and treatment (9 papers), Genetic Neurodegenerative Diseases (7 papers), Alzheimer's disease research and treatments (7 papers) and Parkinson's Disease and Spinal Disorders (7 papers). The work is most often cited by research in Neurology (4.7k citations), Neurology (1.2k citations), Cellular and Molecular Neuroscience (2.4k citations), Physiology (1.0k citations) and Psychiatry and Mental health (493 citations). G. Meco has collaborated with scholars based in Italy, Netherlands and France. Frequent co-authors include Vincenzo Bonifati, Nicola Vanacore, Ben A. Oostra, Alexis Brice, Peter Heutink, Cornelia M. van Duijn, Ferdinando Squitieri, Patrizia Rizzu, John C. van Swieten and Guido J. Breedveld. Their work appears in journals such as Neurological Sciences, Acta Neurologica Scandinavica, Movement Disorders, Neurology and Journal of Neural Transmission.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact